Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcineurin inhibitors might be safer than steroids for scarring alopecia, but more research is needed.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Antioxidants helped reduce prednisolone dosage and improved hair growth in alopecia areata patients.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Trilostane helped a dog with an adrenal tumor feel better and stay healthy.

Oral tacrolimus may be a potential treatment for hair loss that doesn't respond to corticosteroids.

Systemic steroids temporarily improve severe alopecia areata in children but often lead to relapse.

Stopping steroids and providing supportive care improved the patient's Cushing Syndrome symptoms and ulcers.

Pharmacists are key in choosing and guiding the safe use of topical corticosteroids for skin conditions.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

Oral cyclosporine A and prednisolone effectively improved alopecia universalis without side effects.

17-beta estradiol and prednisolone may help regrow hair damaged by chemotherapy.

Use lower concentrations of triamcinolone acetonide to reduce steroid-induced scalp atrophy.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Ice-skating athletes often have skin problems due to cold, infections, and inflammation, needing careful treatment and prevention.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.